Tradestie Institutional Equity Comparison Engine

JNJ vs BOLD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

JNJ Overall Edge

JNJ Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Johnson & Johnson (JNJ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, JNJ trades at 23.3x Forward P/E with 26.6% operating margin (+5.9% YoY revenue) versus BOLD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, JNJ sits in CONSOLIDATION (45th %ile IV; Dealer Gamma Walls on Pro) against BOLD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner JNJ
JNJ 23.3x vs BOLD N/M Fwd P/E
Growth & Margin Winner JNJ
Op Margin 26.6% vs 0.0% ยท YoY +5.9% vs +0.0%
Momentum & Technical Winner JNJ
1Y +33.6% vs +101.7% ยท 52W Pos 78% vs 62%
Options & Structure Winner JNJ
CONSOLIDATION (45th %ile IV) vs UNCLASSIFIED (N/A IV)
JNJ NYSE
Johnson & Johnson
Pharmaceutical Preparations
$270.47
+1.25% 1D
Market Cap $643.1B
1M Return +1.07%
1Y Return +33.56%
Forward P/E 23.3x
Unified AI Score
57.8 / 100 HOLD
Tech 47.0 Fund 54.0 Flow 66.0 Mom 50.0
BOLD NASDAQ
Boundless Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.32
-2.52% 1D
Market Cap $56.2M
1M Return -4.92%
1Y Return +101.74%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 25.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: JNJ +33.56% BOLD +101.74% Spread: +68.18 pp (BOLD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
JNJ TTM Op. Margin: 26.6% BOLD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JNJ vs BOLD. Trailing 12-month operating profitability (JNJ 26.6% vs BOLD 0.0%) and valuation multiples (JNJ 23.3x vs BOLD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: JNJ (10) vs BOLD (0)
Institutional Metric JNJ BOLD Criterion Row Winner
Market Capitalization Scale $643.1B $56.2M Larger Scale JNJ
Trailing P/E Ratio Valuation 40.5x N/M Lower Multiple JNJ
Forward P/E Ratio Valuation 23.3x N/M Lower Multiple JNJ
Revenue Growth (YoY) Growth +5.9% +0.0% Higher Growth JNJ
Operating Margin (TTM) Profitability 26.6% 0.0% Higher Margin JNJ
Net Profit Margin Profitability 16.2% 0.0% Higher Margin JNJ
Return on Equity (ROE) Capital Efficiency 20.0% -64.6% Higher ROE JNJ
52-Week Range Position Momentum 78% ($199โ€“$290) 62% ($1โ€“$3) Stronger Trend JNJ
Beta / 30D Volatility Risk Regime -0.04ฮฒ ยท 25% Vol -0.08ฮฒ ยท 28% Vol Lower Realized Risk JNJ
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 36.8 / 100 (SELL) Higher Composite JNJ

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full JNJ vs BOLD Buy Guide
JNJ CONSOLIDATION
66d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 45th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live JNJ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BOLD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BOLD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither JNJ nor BOLD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.